Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification Number)
|
Title of each class:
|
Trading Symbol(s)
|
Name of each exchange on which registered:
|
|
|
|
The
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
☒
|
Smaller reporting company
|
|
Emerging growth company
|
|
1
|
|
1 |
|
21 |
|
37 |
|
37 |
|
38 |
|
38 |
|
40 |
|
40 |
|
40 |
|
40 |
|
40 |
|
40 |
|
41 |
● |
general economic and business conditions, including changes in interest rates;
|
● |
prices of other EVs, costs associated with manufacturing EVs and other economic conditions;
|
● |
the effect of an outbreak of disease or similar public health threat, such as the COVID-19 pandemic, on the Company’s business (natural phenomena, including the
lingering effects of the COVID-19 pandemic);
|
● |
the impact of political unrest, natural disasters or other crises, terrorist acts, acts of war and/or military operations, and our ability to maintain or broaden
our business relationships and develop new relationships with strategic alliances, suppliers, customers, distributors or otherwise;
|
● |
breaches in data security, failure of information security systems, cyber-attacks or other security or privacy-related incidents affecting us or our suppliers;
|
● |
the ability of our information technology systems or information security systems to operate effectively;
|
● |
actions by government authorities, including changes in government regulation;
|
● |
uncertainties associated with legal proceedings;
|
● |
changes in the size of the EV market;
|
● |
future decisions by management in response to changing conditions;
|
● |
the Company’s ability to execute prospective business plans;
|
● |
misjudgments in the course of preparing forward-looking statements;
|
● |
the Company’s ability to raise sufficient funds to carry out its proposed business plan;
|
● |
inability to keep up with advances in EV and battery technology;
|
● |
inability to design, develop, market and sell new EVs and services that address additional market opportunities to generate revenue and positive cash flows;
|
● |
dependency on certain key personnel and any inability to retain and attract qualified personnel;
|
● |
inexperience in mass-producing EVs;
|
● |
inability to succeed in establishing, maintaining and strengthening the Cenntro brand;
|
● |
disruption of supply or shortage of raw materials;
|
● |
the unavailability, reduction or elimination of government and economic incentives;
|
● |
failure to manage future growth effectively; and
|
● |
the other risks and uncertainties detailed from time to time in our filings with the United States Securities and Exchange Commission (“SEC”), including but not
limited to those described under “Risk Factors” in Part I, Item 1A of the Company’s Annual Report on Form 10-K as amended for the year ended December 31, 2023, filed with the SEC on April 1, 2024 (the “Form 10-K”).
|
Page
|
|
Item 1. Interim Financial Statements
|
1
|
1
|
|
2
|
|
3
|
|
4
|
|
5
|
For the Three Months Ended
September 30,
|
For the Nine Months Ended
September 30, |
|||||||||||||||||||
Note
|
2024
|
2023
|
2024
|
2023
|
||||||||||||||||
Net revenues
|
2(d
|
)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Cost of goods sold
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Gross profit
|
|
|
|
|
||||||||||||||||
|
||||||||||||||||||||
OPERATING EXPENSES:
|
||||||||||||||||||||
Selling and marketing expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
General and administrative expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Research and development expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Total operating expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
|
||||||||||||||||||||
Loss from operations
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
|
||||||||||||||||||||
OTHER EXPENSE:
|
||||||||||||||||||||
Interest expense, net
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Loss from long-term investment |
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Loss from acquisition of Antric Gmbh | ( |
) | ( |
) | ||||||||||||||||
Loss from acquisition of Hezhe | ( |
) | ||||||||||||||||||
Impairment of long-term investment
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Gain on redemption of convertible promissory notes |
|
|
|
|
||||||||||||||||
Gain/(Loss) on exercise of warrants
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Change in fair value of convertible promissory notes and derivative liability
|
(
|
)
|
|
|
|
|||||||||||||||
Change in fair value of equity securities
|
8 |
|
(
|
)
|
|
(
|
)
|
|||||||||||||
Foreign currency exchange gain (loss), net |
|
(
|
)
|
|
(
|
)
|
||||||||||||||
(Loss)/ Gain from cross-currency swaps |
( |
) | ||||||||||||||||||
Other (expense) income, net |
( |
) | ( |
) | ||||||||||||||||
Loss before income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Income tax benefit (expense)
|
13
|
|
|
|
(
|
)
|
||||||||||||||
Net loss
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Less: net loss attributable to non-controlling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Net loss attributable to the Company’s shareholders
|
$
|
(
|
)
|
$
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||
|
||||||||||||||||||||
OTHER COMPREHENSIVE LOSS
|
||||||||||||||||||||
Foreign currency translation adjustment
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||||||
Total comprehensive loss
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
|
||||||||||||||||||||
Less: total comprehensive loss attributable to non-controlling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Total comprehensive loss to the Company’s shareholders
|
$
|
(
|
)
|
$
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||||||
Weighted average number of shares outstanding, basic and diluted * | ||||||||||||||||||||
Loss per share, basic and diluted * | ( |
) | ( |
) | ( |
) | ( |
) |
Note
|
September 30,
2024
|
December 31,
2023
|
||||||||||
(Unaudited)
|
||||||||||||
ASSETS
|
||||||||||||
Current assets:
|
||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||||||
Restricted cash
|
|
|
||||||||||
Short-term investment |
||||||||||||
Accounts receivable, net
|
4
|
|
|
|||||||||
Inventories
|
5
|
|
|
|||||||||
Prepayment and other current assets
|
6
|
|
|
|||||||||
|
19
|
|
|
|||||||||
Total current assets
|
|
|
||||||||||
Non-current assets:
|
||||||||||||
Long-term investment, net
|
7
|
|
|
|||||||||
Investment in equity securities
|
8
|
|
|
|||||||||
Property, plant and equipment, net
|
9
|
|
|
|||||||||
Goodwill |
||||||||||||
Intangible assets, net
|
10 |
|
|
|||||||||
Right-of-use assets
|
13
|
|
|
|||||||||
Other non-current assets, net
|
|
|
||||||||||
Total non-current assets
|
|
|
||||||||||
Total Assets
|
$
|
|
$
|
|
||||||||
LIABILITIES AND EQUITY
|
||||||||||||
LIABILITIES
|
||||||||||||
Current liabilities:
|
||||||||||||
Accounts payable
|
$ |
|
$ |
|
||||||||
Short-term loans and current portion of long-term loans |
11 |
|||||||||||
Accrued expenses and other current liabilities
|
12 |
|
|
|||||||||
Contractual liabilities
|
|
|
||||||||||
Operating lease liabilities, current
|
14
|
|
|
|||||||||
Convertible promissory notes
|
15
|
|
|
|||||||||
Contingent liabilities |
||||||||||||
Deferred government grant, current
|
|
|
||||||||||
|
19
|
|
|
|||||||||
Total current liabilities
|
|
|
||||||||||
Non-current liabilities:
|
||||||||||||
Long-term loans |
11 |
|||||||||||
Contingent liabilities non-current |
||||||||||||
Deferred tax liabilities |
||||||||||||
Deferred government grant, non-current
|
|
|
||||||||||
Derivative liability - investor warrant
|
15
|
|
|
|||||||||
Derivative liability - placement agent warrant
|
15
|
|
|
|||||||||
Operating lease liabilities, non-current
|
14
|
|
|
|||||||||
Total non-current liabilities
|
|
|
||||||||||
Total Liabilities
|
$
|
|
$
|
|
||||||||
Commitments and contingencies
|
18
|
|||||||||||
EQUITY
|
||||||||||||
Common stock (
|
|
|
||||||||||
Additional paid in capital
|
|
|
||||||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||||||
Total equity attributable to shareholders
|
|
|
||||||||||
Non-controlling interests
|
|
(
|
)
|
|||||||||
Total Equity
|
$
|
|
$
|
|
||||||||
Total Liabilities and Equity
|
$
|
|
$
|
|
Common Stock
|
Additional
paid in capital
|
Accumulated
deficit
|
Accumulated
other
comprehensive
loss
|
Total
shareholders’
equity
|
Non-
controlling
interest
|
Total equity
|
||||||||||||||||||||||||||
Shares *
|
Amount
|
|||||||||||||||||||||||||||||||
Balance as of December 31, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Net loss
|
-
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
Acquisition of
|
-
|
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||||
Exercise of warrants
|
||||||||||||||||||||||||||||||||
Foreign currency translation adjustment
|
-
|
|
|
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
Balance as of September 30, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
Common Stock
|
Additional
paid in capital
|
Accumulated
deficit
|
Accumulated
other
comprehensive
loss
|
Total
shareholders’
equity
|
Non-
controlling
interest
|
Total equity
|
||||||||||||||||||||||||||
Shares
|
Amount
|
|||||||||||||||||||||||||||||||
Balance as of December 31, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Net loss
|
-
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
Acquisition of
|
- | |||||||||||||||||||||||||||||||
Fractional shares issued due to reverse stock split
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Exercise of warrants | ||||||||||||||||||||||||||||||||
Foreign currency translation adjustment
|
-
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||||
Balance as of September 30, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
For the Nine Months Ended
September 30,
|
||||||||
2024
|
2023
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net cash used in operating activities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
Purchase of equity investment
|
|
(
|
)
|
|||||
Purchase of property, plant and equipment
|
(
|
)
|
(
|
)
|
||||
Purchase of land use right and property
|
|
(
|
)
|
|||||
Purchase of other intangible assets | ( |
) | ||||||
Acquisition of CAE's equity interests
|
|
(
|
)
|
|||||
Acquisition of Antric Gmbh's equity interests | ( |
) | ||||||
Cash acquired from acquisition of Antric Gmbh | ||||||||
Net of cash acquired of |
( |
) | ||||||
Purchase of short-term investment | ( |
) | ||||||
Proceeds from short-term investment | ||||||||
Cash dividend received | ||||||||
Proceeds from disposal of property, plant and equipment
|
|
|
||||||
Loans provided to third parties
|
|
(
|
)
|
|||||
Proceeds from interest and redemption of equity securities investment | ||||||||
Net cash provided by (used in) investing activities
|
|
(
|
)
|
|||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Proceeds from bank loans | ||||||||
Repayment of bank loans | ( |
) | ( |
) | ||||
Loans proceed from third parties | ||||||||
Repayment of loans to third parties | ( |
) | ||||||
Redemption of convertible promissory notes
|
|
(
|
)
|
|||||
Net cash provided by (used in) financing activities
|
|
(
|
)
|
|||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
|
(
|
)
|
|||||
Net decrease in cash, cash equivalents and restricted cash
|
(
|
)
|
(
|
)
|
||||
Cash, cash equivalents and restricted cash at beginning of period
|
|
|
||||||
Cash, cash equivalents and restricted cash at end of period
|
$
|
|
$
|
|
||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||
Interest paid
|
$
|
|
$
|
|
||||
Income tax paid
|
$ | $ | ||||||
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
Convention from debt to equity interest of HW Electro Co., Ltd. | $ | $ | ||||||
Cashless exercise of warrants
|
$
|
|
$
|
|
Name
|
Date of
Incorporation
|
Place of
Incorporation
|
Percentage of direct or
indirect economic
interest
|
|||
Cenntro Electric Group Pty Limited (“CEGL”) | ||||||
Cenntro Automotive Corporation (“CAC”)
|
|
|
|
|||
Cenntro Electric Group, Inc. (“CEG”)
|
|
|
|
|||
Cennatic Power, Inc. (“Cennatic Power”)
|
|
|
|
|||
Cenntro Electric Group (Europe) GmbH | ||||||
Teemak Power Corporation
|
|
|
|
|||
Avantier Motors Corporation
|
|
|
|
|||
Cenntro Electric CICS, SRL
|
|
|
|
|||
Cennatic Energy S. de R.L. de C.V.
|
|
|
|
|||
Cenntro Automotive S.A.S.
|
|
|
|
|||
Cenntro Electric Colombia S.A.S.
|
|
|
|
|||
Cenntro Automotive Group Limited (“CAG HK”)
|
|
|
|
|||
Hangzhou Ronda Tech Co., Limited (“Hangzhou Ronda”)
|
|
|
|
|||
Hangzhou Cenntro Autotech Co., Limited (“Cenntro Hangzhou”)
|
|
|
|
|||
Zhejiang Cenntro Machinery Co., Limited
|
|
|
|
|||
Jiangsu Tooniu Tech Co., Limited
|
|
|
|
|||
Hangzhou Hengzhong Tech Co., Limited
|
|
|
|
|||
Teemak Power (Hong Kong) Limited (HK)
|
|
|
|
|||
Avantier Motors (Hong Kong) Limited
|
|
|
|
|||
Cenntro Automotive Europe GmbH (“CAE”)
|
|
|
|
|||
Cenntro Electric B.V.
|
|
|
|
|||
Cenntro Elektromobilite Araçlar A.Ş
|
|
|
|
|||
Cenntro Elecautomotiv, S.L.
|
|
|
|
|||
Cenntro Electric Group (Europe) GmbH (“CEGE”)
|
|
|
|
|||
Simachinery Equipment Limited (“Simachinery HK”)
|
|
|
|
|||
Zhejiang Sinomachinery Co.,
Limited (“Sinomachinery Zhejiang”) *
|
|
|
|
|||
Shengzhou Cenntro Machinery Co.,
Limited (“Cenntro Machinery”) *
|
|
|
|
|||
Cenntro EV Center Italy S.R.L.
|
|
|
|
|||
Antric Gmbh
|
|
|||||
Pikka Electric Corporation
|
|
|||||
Centro Technology Corporation
|
|
|||||
Hangzhou Hezhe Energy Technology Co., Ltd. (“Hangzhou Hezhe”) |
(a) |
Basis of presentation
|
(b) |
Use of estimates
|
(c) |
Fair value measurement
|
(d) |
Revenue recognition
|
For the Nine Months Ended
September 30,
|
||||||||
2024
|
2023
|
|||||||
(Unaudited)
|
(Unaudited) | |||||||
Vehicles sales
|
$
|
|
$
|
|
||||
Spare-parts sales
|
|
|
||||||
Other service income
|
|
|
||||||
Net revenues
|
$
|
|
$
|
|
For the Nine Months Ended
September 30,
|
||||||||
2024
|
2023
|
|||||||
(Unaudited) | (Unaudited) | |||||||
Primary geographical markets
|
|
|||||||
America
|
$
|
|
$
|
|
||||
Europe
|
|
|
||||||
Asia
|
|
|
||||||
Others | ||||||||
Total
|
$
|
|
$
|
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
Accounts receivable, net
|
$
|
|
$
|
|
||||
Contractual liabilities
|
$
|
|
$
|
|
(e) |
Recently issued accounting standards pronouncement
|
|
As of May 21 2024
|
|||||||||
|
RMB
|
USD
|
Amortization Period
|
|||||||
Current assets (1)
|
|
|
|
|||||||
Property and equipment
|
|
|
|
|||||||
Goodwill
|
|
|
|
|||||||
Current liabilities
|
(
|
)
|
(
|
)
|
||||||
Deferred tax liabilities
|
(
|
)
|
(
|
)
|
|
|||||
Noncontrolling interest
|
(
|
)
|
(
|
)
|
||||||
Total
|
|
|
|
(1) |
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
Accounts receivable
|
$
|
|
$
|
|
||||
Less: allowance for
credit losses
|
(
|
)
|
(
|
)
|
||||
Accounts receivable, net
|
$
|
|
$
|
|
For the Nine Months Ended
September 30,
|
||||||||
2024
|
2023
|
|||||||
(Unaudited) |
(Unaudited) |
|||||||
Balance at the beginning of the period
|
$
|
|
$
|
|
||||
Write-off
|
(
|
)
|
(
|
)
|
||||
Foreign exchange
|
|
|
||||||
Balance at the end of the period
|
$
|
|
$
|
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
Raw material
|
$
|
|
$
|
|
||||
Work-in-progress
|
|
|
||||||
Goods in transit
|
|
|
||||||
Finished goods
|
|
|
||||||
Inventories, gross
|
|
|
||||||
Less: Inventory valuation allowance |
( |
) | ( |
) | ||||
Inventories, net |
$ | $ |
For the Nine Months Ended
September 30,
|
||||||||
2024
|
2023
|
|||||||
(Unaudited) | (Unaudited) | |||||||
Balance at the beginning of the period
|
$
|
|
$
|
|
||||
Addition during the period |
||||||||
Write-off (1)
|
(
|
)
|
(
|
)
|
||||
Foreign exchange |
(
|
)
|
(
|
)
|
||||
Balance at the end of the period
|
$
|
|
$
|
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
Advance to suppliers
|
$
|
|
$
|
|
||||
Deductible input value added tax
|
|
|
||||||
Receivable from third parties
|
|
|
||||||
Others
|
|
|
||||||
Prepayment and other current assets
|
$
|
|
$
|
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
Hangzhou Entropy Yu Equity Investment Partnership (Limited Partnership) (“Entropy Yu”) (1)
|
$
|
|
$
|
|
||||
Hangzhou Hezhe Energy Technology Co., Ltd. (“Hangzhou Hezhe”) (2)
|
|
|
||||||
Able 2rent GmbH (DEU) (3)
|
|
|
||||||
Total
|
$
|
|
$
|
|
(1) |
|
(2) |
|
(3) |
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
HW Electro Co., Ltd. (1)
|
$
|
|
$
|
|
||||
Robostreet Inc. (2)
|
||||||||
Total
|
$
|
|
$
|
|
(1) |
|
(2) |
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
MineOne Fix Income Investment I L.P
|
$
|
|
$
|
|
||||
Micro Money Fund SPC
|
|
|
||||||
Total
|
$
|
|
$
|
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
At cost:
|
||||||||
Plant and building
|
$
|
|
$
|
|
||||
Land |
||||||||
Machinery and equipment
|
|
|
||||||
Leasehold improvement
|
|
|
||||||
Office equipment
|
|
|
||||||
Motor vehicles
|
|
|
||||||
Construction in progress |
||||||||
Total
|
|
|
||||||
Less: accumulated depreciation
|
(
|
)
|
(
|
)
|
||||
Impairment
|
( |
) | ( |
) | ||||
Property, plant and equipment, net
|
$
|
|
$
|
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
At cost:
|
||||||||
Land use right
|
$
|
|
$
|
|
||||
Trademark |
||||||||
Technology |
||||||||
Software
|
|
|
||||||
Total
|
|
|
||||||
Less: accumulated amortization
|
(
|
)
|
(
|
)
|
||||
Intangible assets, net
|
$
|
|
$
|
|
As of September 30,
2024
(Unaudited)
|
As of December 31,
2023
|
|||||||||||||||||||||||||
Bank and other financial institution
|
Annual Interest Rate
|
Start
|
Maturity
|
Principal
|
Current
portion
|
Non-
current
portion |
Current
portion
|
Non-
current
portion |
||||||||||||||||||
Bank of Multiple Promerica Republic Dominicana
|
(1) |
|
%
|
and |
and |
|
|
|
|
|
||||||||||||||||
Bank of Multiple Promerica Republic
Dominicana
|
(2) | % |
and |
and | ||||||||||||||||||||||
Total
|
|
|
|
|
|
(1)
|
|
(2)
|
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
Accrued litigation compensation
|
$
|
|
$
|
|
||||
Other taxes payable
|
|
|
||||||
Accrued expenses
|
|
|
||||||
Interest-free loan provided by third parties
|
|
|
||||||
Returns payable
|
|
|
||||||
Employee payroll and welfare payables
|
|
|
||||||
Credit card payable
|
|
|
||||||
Accrued professional fees
|
|
|
||||||
Others
|
|
|
||||||
Total
|
$
|
|
$
|
|
For the Nine Months Ended
September 30,
|
||||||||
2024
|
2023
|
|||||||
(Unaudited)
|
(Unaudited) |
|||||||
PRC |
$
|
|
$
|
|
||||
Europe | ||||||||
US
|
|
|
||||||
Australia
|
|
|
||||||
Others
|
|
|
||||||
Total
|
$
|
|
$
|
|
For the Nine Months Ended September 30,
|
||||||||
2024
|
2023
|
|||||||
(Unaudited) | (Unaudited) | |||||||
Operating leases cost excluding short-term rental expense
|
$
|
|
$
|
|
||||
Short-term lease cost
|
|
|
||||||
Total
|
$
|
|
$
|
|
September 30,
2024
|
September 30,
2023
|
|||||||
(Unaudited) | (Unaudited) | |||||||
Cash paid for amounts included in the measurement of lease liabilities
|
$
|
|
$
|
|
||||
Weighted average remaining lease term
|
|
|
||||||
Weighted average discount rate
|
|
%
|
|
%
|
Operating
Leases
|
||||
For the remaining of 2024
|
$
|
|
||
Years ended December 31,
|
||||
2025
|
|
|||
2026
|
|
|||
2027
|
|
|||
2028
|
|
|||
2029 and thereafter
|
|
|||
Total lease payments
|
|
|||
Less: imputed interest
|
|
|||
Total
|
|
|||
Less: |
|
|||
$
|
|
Liability component
|
||||
As of December 31, 2023
|
$
|
|
||
Convertible promissory notes issued during the year
|
|
|||
Redemption of convertible promissory notes
|
|
|||
Fair value change recognized
|
(
|
)
|
||
As of September 30, 2024 (Unaudited)
|
|
Fair Value Assumptions - Convertible Promissory Note
|
September 30,
2024
|
December 31,
2023
|
||||||
Face value principal payable
|
|
|
||||||
Original conversion price
|
|
|
||||||
Interest Rate
|
|
%
|
|
%
|
||||
Expected term (years)
|
|
|
||||||
Volatility
|
|
%
|
|
%
|
||||
Market yield (range)
|
|
%
|
|
%
|
||||
Risk free rate
|
|
%
|
|
%
|
||||
Issue date
|
|
|
||||||
Maturity date
|
|
|
Investor warrants component
|
Placement agent warrants component
|
|||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||
As of December 31, 2023
|
$
|
|
$
|
|
||||||||||||
Exercise of warrants
|
( |
) |
(
|
)
|
|
|||||||||||
Fair value change recognized
|
|
|
||||||||||||||
As of September 30, 2024 (Unaudited)
|
|
|
Fair Value Assumptions – Warrants
|
September 30,
2024
|
December 31,
2023
|
||||||
Expected term (years)
|
|
|
||||||
Volatility
|
|
%
|
|
%
|
||||
Risk free rate
|
|
%
|
|
%
|
||||
Expected expiry date |
|
|
For the Nine Months Ended September 30,
|
|
|||||
|
|
2024
|
|
|
2023
|
|
||
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
||
General and administrative expenses
|
|
$
|
|
|
|
$
|
|
|
Selling and marketing expenses
|
|
|
|
|
|
|
|
|
Research and development expenses
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
|
|
|
$
|
|
|
|
Number of
Share
Options
|
Weighted
Average
Exercise Price
US$
|
Weighted
Average
Remaining
Contractual
Years
|
Aggregate
Intrinsic
Value
US$
|
||||||||||||
Outstanding at December 31, 2022(After the “Share Consolidation”) *
|
|
|
|
|
||||||||||||
Granted
|
|
|
||||||||||||||
Exercised
|
|
|
||||||||||||||
Forfeited
|
(
|
)
|
|
|||||||||||||
Expired
|
(
|
)
|
|
|||||||||||||
Outstanding at September 30, 2023(Unaudited, after the “Share
Consolidation”)*
|
|
|
|
|
||||||||||||
Outstanding at December 31, 2023 (After the “Share
Consolidation”)*
|
|
|
|
|
||||||||||||
Granted
|
|
|
||||||||||||||
Exercised
|
|
|
||||||||||||||
Forfeited
|
(
|
)
|
|
|||||||||||||
Expired
|
(
|
)
|
|
|||||||||||||
Outstanding at September 30, 2024 (unaudited)
|
|
|
|
|
||||||||||||
Expected to vest at September 30, 2024 (unaudited)
|
|
|
|
|
||||||||||||
Exercisable as of September 30, 2024 (unaudited)
|
|
|
|
|
|
For the Nine Months Ended September 30,
|
|||||
|
2024
|
2023
|
||||
Expected volatility
|
|
|
||||
Expected dividends yield
|
|
|
|
|
||
Risk-free interest rate per annum
|
|
|
||||
The fair value of underlying common stock (per share)
|
$
|
$
|
(a) |
Customers
|
Nine Months ended
|
Nine Months ended
|
||||||||||||||||
September 30, 2024,
(Unaudited)
|
September 30, 2023,
(Unaudited)
|
||||||||||||||||
Customer
|
Amount |
% of Total
|
Amount
|
% of Total
|
|||||||||||||
A
|
$
|
|
|
$
|
|
|
%
|
||||||||||
Total
|
$
|
|
|
$
|
|
|
%
|
*
|
|
As of September 30, 2024, (Unaudited)
|
As of December 31, 2023,
|
|||||||||||||||
Customer |
Amount
|
% of Total |
Amount
|
% of Total |
||||||||||||
A |
$ | % | $ | |||||||||||||
B |
|
|
%
|
|
|
%
|
||||||||||
C |
|
|
|
%
|
||||||||||||
Total |
$
|
|
|
%
|
$
|
|
|
%
|
*
|
Indicates below 10%.
|
As of September 30, 2024,
(Unaudited)
|
As of December 31, 2023,
|
||||||||||||||||
Customer
|
Amount
|
% of Total
|
Amount
|
% of Total
|
|||||||||||||
A
|
$
|
|
|
%
|
$
|
|
|
%
|
|||||||||
D
|
|
|
%
|
|
|
%
|
|||||||||||
E |
|
|
|
|
%
|
||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
(b)
|
Suppliers
|
Nine Months ended
September 30, 2024,
(Unaudited)
|
Nine Months ended
September 30, 2023,
(Unaudited)
|
|||||||||||||||
Supplier
|
Amount
|
% of Total
|
Amount
|
% of Total
|
||||||||||||
A
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||
B |
% | |||||||||||||||
C |
% | |||||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
*
|
Indicates below 10%.
|
As of September 30, 2024, (Unaudited)
|
As of December 31, 2023,
|
|||||||||||||||
Supplier
|
Amount
|
% of Total
|
Amount
|
% of Total
|
||||||||||||
A
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||
B
|
|
|
|
|
%
|
|||||||||||
C
|
|
|
%
|
|
|
%
|
||||||||||
D
|
|
|
%
|
|
|
%
|
||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
Name of related parties:
|
Relationship with the Company
|
|
Zhejiang RAP
|
|
|
Hangzhou Hezhe
|
|
|
Billy Rafael Romero Del Rosario
|
|
|
For the Nine
Months Ended
September 30,
|
|||||||
|
2024
|
2023
|
||||||
(Unaudited) | (Unaudited) | |||||||
Zhejiang RAP | ||||||||
Purchase of raw materials from related parties
|
||||||||
Hangzhou Hezhe (1)
|
|
|
||||||
|
||||||||
Payment on the purchase of the raw materials
|
||||||||
Hangzhou Hezhe (1)
|
|
|
||||||
|
||||||||
Refund on the purchase of the raw materials
|
||||||||
Hangzhou Hezhe (1)
|
|
|
||||||
|
||||||||
Prepayment of operating fund to a related party
|
||||||||
Billy Rafael Romero Del Rosario
|
|
|
(1) |
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
Billy Rafael Romero Del Rosario (1)
|
$ | $ | ||||||
Zhejiang RAP
|
||||||||
Hangzhou Hezhe |
$ |
|||||||
Total
|
$
|
|
$
|
|
|
(1) |
|
September 30,
2024
(Unaudited)
|
December 31,
2023
|
|||||||
Zhejiang RAP
|
$
|
|
$
|
|
||||
Total
|
$
|
|
$
|
|
ITEM 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Nine Months ended September 30,
|
||||||||
2024
|
2023
|
|||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
|||||||
Gross margin of vehicle sales
|
19.2
|
%
|
16.3
|
%
|
Three Months ended September 30,
|
Nine Months ended September 30,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||
Combined Statements of Operations Data:
|
||||||||||||||||
Net revenues
|
16,731,340
|
5,762,831
|
28,443,831
|
13,470,895
|
||||||||||||
Cost of goods sold
|
(12,688,393
|
)
|
(5,045,364
|
)
|
(23,161,743
|
)
|
(11,411,439
|
)
|
||||||||
Gross profit/(loss)
|
4,042,947
|
717,467
|
5,282,088
|
2,059,456
|
||||||||||||
Operating Expenses:
|
||||||||||||||||
Selling and marketing expenses
|
(5,027,864
|
)
|
(2,626,829
|
)
|
(7,651,305
|
)
|
(7,238,563
|
)
|
||||||||
General and administrative expenses
|
(7,934,755
|
)
|
(9,071,910
|
)
|
(21,945,891
|
)
|
(25,715,387
|
)
|
||||||||
Research and development expenses
|
(1,476,684
|
)
|
(1,634,796
|
)
|
(4,292,153
|
)
|
(5,347,785
|
)
|
||||||||
Total operating expenses
|
(14,439,303
|
)
|
(13,333,535
|
)
|
(33,889,349
|
)
|
(38,301,735
|
)
|
||||||||
Loss from operations
|
(10,396,356
|
)
|
(12,616,068
|
)
|
(28,607,261
|
)
|
(36,242,279
|
)
|
||||||||
Other Income (Expense):
|
||||||||||||||||
Interest expense, net
|
(34,198
|
)
|
(84,573
|
)
|
(58,744
|
)
|
(137,726
|
)
|
||||||||
Loss from equity method investments
|
(11,152
|
)
|
(107,069
|
)
|
(28,262
|
)
|
(236,672
|
)
|
||||||||
Loss from acquisition of Antric Gmbh
|
-
|
(1,316,772
|
)
|
-
|
(1,316,772
|
)
|
||||||||||
Loss from acquisition of Hezhe
|
-
|
-
|
(149,872
|
)
|
-
|
|||||||||||
Impairment of Long-term investments
|
-
|
(2,668
|
)
|
-
|
(1,157,334
|
)
|
||||||||||
Gain on redemption of convertible promissory notes
|
-
|
966
|
-
|
865
|
||||||||||||
Gain/(Loss) on exercise of warrants
|
910
|
(1,134
|
)
|
910
|
(228,749
|
)
|
||||||||||
Change in fair value of convertible promissory notes and derivative liability
|
(6,724
|
)
|
15,143
|
1,808
|
88,568
|
|||||||||||
Change in fair value of equity securities
|
262,417
|
(1,879,593
|
)
|
756,868
|
(1,166,125
|
)
|
||||||||||
Foreign currency exchange gain/(loss), net
|
1,838,505
|
(311,204
|
)
|
1,108,826
|
(1,667,475
|
)
|
||||||||||
Gain (loss) from cross-currency swaps
|
(705
|
)
|
-
|
882
|
-
|
|||||||||||
Other (expense) income, net
|
(646,718
|
)
|
199,389
|
(477,909
|
)
|
794,441
|
||||||||||
Loss before income taxes
|
(8,994,021
|
)
|
(16,103,583
|
)
|
(27,452,754
|
)
|
(41,269,258
|
)
|
||||||||
Income tax benefit/(expense)
|
12,434
|
384
|
47,149
|
(25,084
|
)
|
|||||||||||
Net loss
|
(8,981,587
|
)
|
(16,103,199
|
)
|
(27,405,605
|
)
|
(41,294,342
|
)
|
||||||||
Less: net loss attributable to non-controlling interests
|
(9,815
|
)
|
(534
|
)
|
(20,855
|
)
|
(159,244
|
)
|
||||||||
Net loss attributable to shareholders of the Company
|
(8,971,772
|
)
|
(16,102,665
|
)
|
(27,384,750
|
)
|
(41,135,098
|
)
|
Three Months ended September 30,
|
Nine Months ended September 30,
|
|||||||||||||||||||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||||||||||||||||||
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
|||||||||||||||||||||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||||||||||||||||||
Net revenues:
|
||||||||||||||||||||||||||||||||
Vehicle Sales
|
$
|
15,873,300
|
94.9
|
%
|
$
|
5,506,589
|
95.6
|
%
|
$
|
25,483,836
|
89.6
|
%
|
$
|
12,732,639
|
94.5
|
%
|
||||||||||||||||
Spare-part sales
|
805,793
|
4.8
|
%
|
241,930
|
4.2
|
%
|
2,783,954
|
9.8
|
%
|
586,632
|
4.4
|
%
|
||||||||||||||||||||
Other sales
|
52,247
|
0.3
|
%
|
14,312
|
0.2
|
%
|
176,041
|
0.6
|
%
|
151,624
|
1.1
|
%
|
||||||||||||||||||||
Total net revenues
|
$
|
16,731,340
|
100.0
|
%
|
$
|
5,762,831
|
100.0
|
%
|
$
|
28,443,831
|
100.0
|
%
|
$
|
13,470,895
|
100.0
|
%
|
Three Months ended September 30,
|
Nine Months ended September 30,
|
|||||||||||||||||||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||||||||||||||||||
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
|||||||||||||||||||||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||||||||||||||||||
Cost of goods sold:
|
||||||||||||||||||||||||||||||||
Vehicle Sales
|
$
|
(8,195,192
|
)
|
64.6
|
%
|
$
|
(4,639,338
|
)
|
92.0
|
%
|
$
|
(14,913,358
|
)
|
64.4
|
%
|
$
|
(10,662,446
|
)
|
93.4
|
%
|
||||||||||||
Spare-part sales
|
(483,249
|
)
|
3.8
|
%
|
(383,722
|
)
|
7.6
|
%
|
(2,376,339
|
)
|
10.3
|
%
|
(584,807
|
)
|
5.1
|
%
|
||||||||||||||||
Other sales
|
(51,787
|
)
|
0.4
|
%
|
(22,304
|
)
|
0.4
|
%
|
(187,990
|
)
|
0.8
|
%
|
(164,186
|
)
|
1.5
|
%
|
||||||||||||||||
Inventory write-down
|
(3,958,165
|
)
|
31.2
|
%
|
-
|
-
|
(5,684,056
|
)
|
24.5
|
%
|
-
|
-
|
||||||||||||||||||||
Total cost of goods sold
|
$
|
(12,688,393
|
)
|
100.0
|
%
|
$
|
(5,045,364
|
)
|
100.0
|
%
|
$
|
(23,161,743
|
)
|
100.0
|
%
|
$
|
(11,411,439
|
)
|
100.0
|
%
|
• |
as a measurement of operating performance because it assists us in comparing the operating performance of our business on a consistent basis, as it removes the impact of items not directly resulting from our core operations;
|
• |
for planning purposes, including the preparation of our internal annual operating budget and financial projections;
|
• |
to evaluate the performance and effectiveness of our operational strategies; and
|
• |
to evaluate our capacity to expand our business.
|
• |
such measures do not reflect our cash expenditures;
|
• |
such measures do not reflect changes in, or cash requirements for, our working capital needs;
|
• |
although depreciation and amortization are recurring, non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and such measures do not reflect any cash requirements for such
replacements; and
|
• |
the exclusion of stock-based compensation expense, which has been a significant recurring expense and will continue to constitute a significant recurring expense for the foreseeable future, as equity awards are expected to continue
to be an important component of our compensation strategy.
|
Three Months ended September 30,
|
Nine Months ended September 30,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||
Net loss
|
$
|
(8,981,587
|
)
|
$
|
(16,103,199
|
)
|
$
|
(27,405,605
|
)
|
$
|
(41,294,342
|
)
|
||||
Interest expense, net
|
34,198
|
84,573
|
58,744
|
137,726
|
||||||||||||
Income tax expense/(benefit)
|
(12,434
|
)
|
(384
|
)
|
(47,149
|
)
|
25,084
|
|||||||||
Depreciation and amortization
|
630,270
|
425,217
|
1,605,514
|
1,213,489
|
||||||||||||
Share-based compensation expense
|
870,094
|
2,154,710
|
2,643,214
|
4,565,000
|
||||||||||||
Gain on redemption of convertible promissory notes
|
-
|
(966
|
)
|
-
|
(865
|
)
|
||||||||||
Loss/(gain) on exercise of warrants
|
(910
|
)
|
1,134
|
(910
|
)
|
228,749
|
||||||||||
Change in fair value of convertible promissory notes and derivative liability
|
6,724
|
(15,143
|
)
|
(1,808
|
)
|
(88,568
|
)
|
|||||||||
Loss from acquisition of Antric
|
-
|
1,316,772
|
-
|
1,316,772
|
||||||||||||
Adjusted EBITDA
|
$
|
(7,453,645
|
)
|
$
|
(12,137,286
|
)
|
$
|
(23,148,000
|
)
|
$
|
(33,896,955
|
)
|
• |
The costs of bringing our new facilities into operation;
|
• |
The timing and costs involved in rolling out new ECV models to market;
|
• |
Our ability to manage the costs of manufacturing our ECVs;
|
• |
The costs of maintaining, expanding and protecting our intellectual property portfolio, including potential litigation costs and liabilities;
|
• |
Revenues received from sales of our ECVs;
|
• |
The costs of additional general and administrative personnel, including accounting and finance, legal and human resources, as well as costs related to litigation, investigations, or settlements;
|
• |
Our ability to collect future revenues; and
|
• |
Other risks discussed in the section titled “Risk Factors.”
|
Nine Months ended September 30,
|
||||||||
2024
|
2023
|
|||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
|||||||
Net cash used in operating activities
|
$
|
(12,912,011
|
)
|
$
|
(45,588,906
|
)
|
||
Net cash (used in) provided by investing activities
|
4,858,042
|
(12,913,713
|
)
|
|||||
Net cash (used in) provided by financing activities
|
1,243,068
|
(48,136,596
|
)
|
|||||
Effect of exchange rate changes on cash
|
70,752
|
(2,614,204
|
)
|
|||||
Net (decrease) increase in cash, cash equivalents, and restricted cash
|
(6,740,149
|
)
|
(109,253,419
|
)
|
||||
Cash and cash equivalents, and restricted cash at beginning of the year
|
29,571,897
|
154,096,801
|
||||||
Cash and cash equivalents, and restricted cash at end of the period
|
$
|
22,831,748
|
$
|
44,843,382
|
For the Nine Months ended
September 30,
|
||||||||
2024
|
2023
|
|||||||
(Unaudited)
|
(Unaudited)
|
|||||||
Vehicles sales
|
|
$
|
25,483,836
|
|
|
$
|
12,732,639
|
|
Spare-parts sales
|
|
|
2,783,954
|
|
|
|
586,632
|
|
Other service income
|
|
|
176,041
|
|
|
|
151,624
|
|
Net revenues
|
|
$
|
28,443,831
|
|
|
$
|
13,470,895
|
|
For the Nine Months ended
September 30, |
||||||||
2024
|
2023
|
|||||||
(Unaudited)
|
(Unaudited)
|
|||||||
Primary geographical markets
|
|
|
|
|
||||
Europe
|
$
|
17,071,721
|
|
|
$
|
451,848
|
||
Asia
|
7,260,544
|
10,035,492
|
||||||
America
|
|
|
4,080,473
|
2,983,555
|
|
|||
Others
|
31,093
|
-
|
||||||
Total
|
|
$
|
28,443,831
|
|
|
$
|
13,470,895
|
|
September 30,
2024
|
December 31,
2023
|
|||||||
(Unaudited)
|
(Unaudited)
|
|||||||
Accounts receivable, net
|
$
|
4,556,857
|
$
|
6,530,801
|
||||
Contractual liabilities
|
$
|
4,958,315
|
$
|
3,394,044
|
ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
ITEM 4. |
CONTROLS AND PROCEDURES
|
ITEM 1. |
LEGAL PROCEEDINGS
|
ITEM 1A. |
RISK FACTORS
|
ITEM 2. |
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
ITEM 3. |
DEFAULTS UPON SENIOR SECURITIES
|
ITEM 4. |
MINE SAFETY DISCLOSURES
|
ITEM 5. |
OTHER INFORMATION
|
Exhibit
No.
|
Description of Exhibit
|
|
Certification of Principal Executive Officer required by Rule 13a-14(a).
|
||
Certification of Principal Financial Officer required by Rule 13a-14(a).
|
||
Certification required by Section 1350 of Chapter 63 of Title 18 of the United States Code.
|
||
101.INS*
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
101.SCH*
|
Inline XBRL Taxonomy Extension Schema Document
|
|
101.CAL*
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF*
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB*
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE*
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
104*
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101)
|
* |
Filed herewith.
|
** |
Furnished herewith.
|
Dated: November 12, 2024
|
||
CENNTRO INC.
|
||
By:
|
/s/ Peter Z. Wang
|
|
Peter Z. Wang
|
||
Chief Executive Officer
|
||
(Principal Executive Officer)
|
||
By:
|
/s/ Edward Ye
|
|
Edward Ye
|
||
Acting Chief Financial Officer
|
||
(Principal Financial and Accounting Officer)
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the company, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c) |
Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and
|
(d) |
Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely
to materially affect, the company’s internal control over financial reporting; and
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record,
process, summarize and report financial information; and
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
|
Dated November 12, 2024
|
||
By:
|
/s/ Peter Z. Wang
|
|
Peter Z. Wang
|
||
Chairman and Chief Executive Officer
|
||
(Principal Executive Officer)
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the company, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c) |
Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and
|
(d) |
Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to
materially affect, the company’s internal control over financial reporting; and
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record,
process, summarize and report financial information; and
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
|
Dated: November 12, 2024
|
||
By:
|
/s/ Edward Ye
|
|
Edward Ye
|
||
Acting Chief Financial Officer
|
||
(Principal Accounting Officer and Principal Financial Officer)
|
Dated: November 12, 2024
|
||
By:
|
/s/ Peter Z. Wang
|
|
Peter Z. Wang
|
||
Chairman and Chief Executive Officer
|
||
(Principal Executive Officer) |
||
By:
|
/s/ Edward Ye
|
|
Edward Ye
|
||
Acting Chief Financial Officer
|
||
(Principal Financial and Accounting Officer) |